Natriuretic Peptides and Long-Term Mortality in Patients with Severe Aortic Stenosis

Imagem de Miniatura
Arquivos
art_KATZ_Natriuretic_Peptides_and_Long_Term_Mortality_in_Patients_2012.PDF (121.73 KB)
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2012
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
I C R PUBLISHERS
Autores
KATZ, Marcelo
PESARO, Antonio Eduardo Pereira
LOPES, Renato D.
Citação
JOURNAL OF HEART VALVE DISEASE, v.21, n.3, p.331-336, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and aim of the study: The natriuretic peptides, brain natriuretic peptide (BNP) and its N-terminal prohormone (NT-proBNP), can be used as diagnostic and prognostic markers for aortic stenosis (AS). However, the association between BNP, NT-proBNP, and long-term clinical outcomes in patients with severe AS remains uncertain. Methods: A total of 64 patients with severe AS was prospectively enrolled into the study, and underwent clinical and echocardiographic assessments at baseline. Blood samples were drawn for plasma BNP and NT-proBNP analyses. The primary outcome was death from any cause, through a six-year follow up period. Cox proportional hazards modeling was used to examine the association between natriuretic peptides and long-term mortality, adjusting for important clinical factors. Results: During a mean period of 1,520 681 days, 51 patients (80%) were submitted to aortic valve replacement, and 13 patients (20%) were medically managed without surgical interventions. Mortality rates were 13.7% in the surgical group and 62% in the medically managed group (p <0.001). Patients with higher plasma BNP (>135 pg/ml) and NT-proBNP (>1,150 pg/ml) levels at baseline had a greater risk of long-term mortality (hazard ratio [HR] 3.2, 95% confidence interval [CI] 1.1-9.1; HR 4.3, 95% CI 1.4-13.5, respectively). After adjusting for important covariates, both BNP and NT-proBNP remained independently associated with long-term mortality (HR 2.9, 95%CI 1.5-5.7; HR 1.8, 95%CI 1.1-3.1, respectively). Conclusion: In patients with severe AS, plasma BNP and NT-proBNP levels were associated with long-term mortality. The use of these biomarkers to guide treatment might represent an interesting approach that deserves further evaluation. The Journal of Heart Valve Disease 2012;21:331-336
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/1499
Referências
  1. Bergler-Klein J, 2004, CIRCULATION, V109, P2302, DOI 10.1161/01.CIR.0000126825.50903.18
  2. Bonow RO, 2008, CIRCULATION, V2008, p[118, e523], DOI 10.1161/CIRCULATI0NAHA.108.190748
  3. Carabello BA, 2002, CIRCULATION, V105, P1746, DOI 10.1161/01.CIR.0000015343.76143.13
  4. Carabello BA, 2002, NEW ENGL J MED, V346, P677, DOI 10.1056/NEJMcp010846
  5. CURRIE PJ, 1985, CIRCULATION, V71, P1162
  6. Dal-Bianco JP, 2008, J AM COLL CARDIOL, V52, P1279, DOI 10.1016/j.jacc.2008.07.020
  7. DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
  8. Gerber IL, 2003, CIRCULATION, V107, P1884, DOI 10.1161/01.CIR.0000060533.79248.0C
  9. Ikeda T, 1997, AM HEART J, V133, P307, DOI 10.1016/S0002-8703(97)70225-4
  10. Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X
  11. Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
  12. Lim P, 2004, EUR HEART J, V25, P2048, DOI 10.1016/j.ehj.2004.09.033
  13. LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220
  14. Nessmith MG, 2005, AM J CARDIOL, V96, P1445, DOI 10.1016/j.amjcard.2005.06.092
  15. Neverdal NO, 2006, EUR J HEART FAIL, V8, P257, DOI 10.1016/j.ejheart.2005.08.004
  16. Otto CM, 1997, CIRCULATION, V95, P2262
  17. Pedrazzini GB, 2008, AM J CARDIOL, V102, P749, DOI 10.1016/j.amjcard.2008.04.055
  18. PELLIKKA PA, 1990, J AM COLL CARDIOL, V15, P1012
  19. Prasad N, 1997, AM HEART J, V133, P477, DOI 10.1016/S0002-8703(97)70196-0
  20. Qi W, 2001, AM HEART J, V142, P725, DOI 10.1067/mhj.2001.117131
  21. Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903
  22. Ross J Jr, 1968, Circulation, V38, P61
  23. Seino Y, 2004, EUR J HEART FAIL, V6, P295, DOI 10.1016/j.ejheart.2003.12.009
  24. Talwar S, 2001, EUR J HEART FAIL, V3, P15, DOI 10.1016/S1388-9842(00)00074-X
  25. Vanderheyden M, 2004, EUR J HEART FAIL, V6, P261, DOI 10.1016/j.ejheart.2004.01.004
  26. Weber M, 2004, AM J CARDIOL, V94, P740, DOI 10.1016/j.amjcard.2004.05.055
  27. WYATT HL, 1980, CIRCULATION, V61, P1119

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor